Mast Cell Activation Syndrome
Sunday, May 18, 2025
Saturday, March 29, 2025
Monday, February 24, 2025
T.
CBC WBC H 11.6 4.0-11.0 x10E3/uL {TC}
RBC 5.07 4.64-6.00 x10E6/uL {TC}
Hgb 15.1 13.5-17.7 gm/dL {TC}
Hct 47 42-53 % {TC}
MCV 93 81-101 fL {TC}
MCHC 31.9 31.1-35.5 gm/dL {TC}
RDW 14.0 11.0-14.5 % {TC}
Platelets 293 150-400 x10E3/uL {TC}
DIFFERENTIAL Diff Type Auto Diff {TC} Neutrophils 75 % {TC}
Lymphocytes 13 % {TC}
Monocytes 10 % {TC}
Eosinophils 2 % {TC}
Basophils 0 % {TC}
Abs. Neutrophil H 8.7 1.8-7.0 x10E3/uL {TC}
Abs. Lymphocyte 1.5 1.0-3.4 x10E3/uL {TC}
Abs. Monocyte H 1.2 0.2-0.8 x10E3/uL {TC}
Abs. Eosinophil 0.2 0.0-0.3 x10E3/uL {TC}
Abs. Basophil 0.0 0.0-0.1 x10E3/uL {TC}
Carbohydrate Ag 19-9 Result H 39 <35 U/mL {TC}
Testing performed by Roche CA19-9 electrochemiluminescent immunoassay. Results obtained with different test methods or kits cannot be used interchangeably. Do not interpret CA 19-9 values as absolute evidence of the presence or the absence of malignant disease. Measurements of CA 19-9 should always be used in conjunction with other diagnostic procedures, including information from the patient's clinical evaluation.
AFP, Tumor Marker H 8.6 <8.4 ng/mL {TC}
Reference range is for nonpregnant subjects only. Fetal production of AFP elevates values in pregnant women. Ranges for newborns are not available, but concentrations over 100,000 ng/mL are not unexpected in normal newborns and AFP concentrations rapidly decline in the first 6 months of life. Testing performed by Roche AFP eletrochemiluminescent immunoassay. Results obtained with different test methods or kits cannot be used interchangeably.
Iron and TIBC Iron 108 45-187 ug/dL {TC}
UIBC 135 ug/dL {TC}
TIBC L 243 250-450 ug/dL {TC}
Iron Sat. 44 20-55 % {TC} Laboratory Report Generated: 2/23/2025 1410
Rheumatoid Factor <10 <14 IU/mL {TC}
CEA 3.3 <3.9 ng/mL {TC}
Testing performed by Roche CEA electrochemiluminescent immunoassay. Results obtained with different test methods or kits cannot be used interchangeably. Do not interpret CEA values as evidence of the presence or the absence of malignant disease. Measurements of CEA should always be used in conjunction with other diagnostic procedures, including information from the patient's clinical evaluation. Smoking slightly increases CEA results.
Vitamin B12/S.Folate
Vitamin B12 383 204-1245 pg/mL {TC}
Serum Folate 19.6 4.6-34.8 ng/mL {TC}
CA 125 11 U/mL {TC} No established reference interval for males. Testing performed by Roche CA 125 II electrochemiluminescent immunoassay. ANA Screen Negative Negative {TC} Method: Multiplex Flow Immunoassay.
IgE Total H 1535.00 <215 kU/L {TC}
Tryptase H 14.7 <=10.9 ug/L


























